UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023491
Receipt number R000027060
Scientific Title A double-blind, randomized, placebo-controlled clinical study to investigate the effect of the beverage containing plant extracts
Date of disclosure of the study information 2017/09/30
Last modified on 2020/04/01 00:03:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A double-blind, randomized, placebo-controlled clinical study to investigate the effect of the beverage containing plant extracts

Acronym

A clinical study to investigate the effect of the beverage containing plant extracts

Scientific Title

A double-blind, randomized, placebo-controlled clinical study to investigate the effect of the beverage containing plant extracts

Scientific Title:Acronym

A clinical study to investigate the effect of the beverage containing plant extracts

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of decreasing VFA (Visceral fat area) level by ingestion of the beverage containing plant extracts

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Visceral fat area, at 8 and 12 weeks after intake

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

The beverage containing plant extract, 12 weeks

Interventions/Control_2

The beverage non-containing plant extract, 12 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1.Males and females equal to or more than 20 years and less than 65 years of age
2.Healthy males and females with no treatment
3.Subjects equal to or more than 25 and less than 30 kg/m^2 of BMI at the pre-study
4.VFA level is above 80 cm^2
5.Subjects who recognize the object and contents of the study and submit the written informed consent

Key exclusion criteria

1.Subjects who have marked impairment of liver, kidney, heart, lung, endocrine, metabolism, nerve, or consciousness, or have DM
2.Subjects who have historical disease of circulatory system disease
3.Subjects who use drugs of glycometabolism, lipidmetabolism, or reducing high blood pressure
4.Subjects who regularly use drugs, health foods, supplements which are suggested causal relationship from the study except who agree to quit taking them
5.Subjects who have allergy related to the test foods
6.Subjects who feel bad mood by blood collection in past
7.Subjects who donated 200 mL or more of blood within a month prior to the study.
8.Subjects who participate in other clinical trials within the last 4 weeks prior to the current study
9.Heavy dinkers or heavy smokers
10.Subjects whose eating habits are extremely irregular
11.Pregnant and lactating female, or who wish to get pregnant during the study period.
12.Subjects who can not agree with preliminary explanation.
13.Subjects who are ineligible due to physician's judgment.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Ikuo
Middle name
Last name Fukuhara

Organization

Fukuhara Clinic

Division name

Director

Zip code

061-1351

Address

3-1-15 Shima-matsuhigashi machi, Eniwa-shi, Hokkaido, Japan

TEL

0123-36-8029

Email

i-feniwa@gray.plala.or.jp


Public contact

Name of contact person

1st name Shimpei
Middle name
Last name Tomita

Organization

New drug research center, Inc.

Division name

Clinical Research Dept.

Zip code

061-1405

Address

452-1Toiso,Eniwa-shi,Hokkaido, Japan

TEL

0123-34-0412

Homepage URL


Email

s-tomita@ndrcenter.co.jp


Sponsor or person

Institute

Fukuhara Clinic

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Miyawaki Orthopedic Clinic IRB

Address

3-1-6, Ariakechou, Eniwa,Hokkaido, Japan

Tel

0123-33-4026

Email

d-kameda@mediffom.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 30 Day


Related information

URL releasing protocol

Unpublished due to the protocol including the intellectual property rights

Publication of results

Published


Result

URL related to results and publications

works in progress,http://www.pieronline.jp/content/article/0386-3603/46080/1383

Number of participants that the trial has enrolled

150

Results

There was a significant difference in primary outcome

Results date posted

2020 Year 03 Month 31 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

overweight

Participant flow

144 participants completed and 150 subjects were incorporated into the analyses

Adverse events

No adverse effect related to the test diets reported

Outcome measures

visceral fat area

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 06 Month 29 Day

Date of IRB

2016 Year 06 Month 29 Day

Anticipated trial start date

2016 Year 08 Month 05 Day

Last follow-up date

2017 Year 12 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 08 Month 04 Day

Last modified on

2020 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027060


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name